A PILOT CLINICAL TRIAL TO MONITOR RESPONSE TO CHEMOTHERAPY USING THE CA-62 MARKER OF EPITHELIAL CARCINOMAS

A PILOT CLINICAL TRIAL TO MONITOR RESPONSE TO CHEMOTHERAPY USING THE CA-62 MARKER OF EPITHELIAL CARCINOMAS

The objective of the study was to assess the feasibility of using CA -62 marker of epithelial carcinomas for monitoring treatment response and detecting cancer progression or recurrence during chemotherapy.Material and Methods. A 12-month double-blind clinical trial was conducted by two independent...

Full description

Saved in:
Bibliographic Details
Main Authors: G. G. Khakimova, Zh. R. Cherkasova, S. A. Tsurkan, G. A. Fedchikov, N. V. Suganov, V. A. Gorbunova
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2019-11-01
Series:Сибирский онкологический журнал
Subjects:
chemotherapy
gastric cancer
small-cell lung cancer
colorectal cancer
neuroendocrine cancer
ovarian cancer
са-62 cancer antigen
immunochemiluminescent assay
cancer marker
monitoring
stable disease
disease progression
Online Access:https://www.siboncoj.ru/jour/article/view/1184
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.siboncoj.ru/jour/article/view/1184

Similar Items